| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.006 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |